A drug originally used to boost the immune system is showing promise as a potential new treatment for lupus, joint Monash University and Peking University research published today shows. Lupus is an autoimmune disease, where the immune system attacks the body’s own organs and tissues.
An international team of scientists from Australia and China have, for the first time, shown in a study published in Nature Medicine, that a natural immune system protein called IL-2 can help restore balance to the overactive immune system of lupus patients. The drug could soon be rolled out for clinical trials in lupus treatment.
Monash Biomedicine Discovery Institute researcher, Dr Di Yu and Professor Zhanguo Li from Peking University People’s Hospital in China co-led the study.
Dr Yu said he hoped the drug could be approved as a lupus treatment within a handful of years.
“This drug, which can help the immune system fight against cancer, was approved in the 1990s but is not commonly used now. We’re now using this drug for a different purpose, based on our new knowledge of the immune system,” Dr Yu said.
“The amount we tested for treating lupus is much less than the dose used in treating cancers. We observed the treatment was safe and showed promising results, so there’s reason to believe formal trials could begin almost immediately,” he said.
Dr Yu said lupus could be a serious disease, and that it hadn’t been able to be treated in a very satisfactory way in the past.
IL-2 is a protein that regulates the activity of white blood cells, which are an important part of the immune system that protect the body against infections. In cancer therapy, patients are given large doses of IL-2 to stimulate their immune system but, paradoxically, the low dose IL-2 given to lupus sufferers in this study actually supressed the overactive part of their immune system that attacks their body. The research also showed the “self-checking” part of the immune system that prevents an overactive immune response, called regulatory T cells, increased after IL-2 treatment.
Professor Eric Morand, fellow Monash University researcher on the study and founder of the Asia Pacific Lupus Collaboration, said that in this study, IL-2 was given to people whose lupus wasn’t responding well to standard treatments.
“The real promise of this treatment is that it calms the hyperactive immune system through multiple mechanisms, which is very important as this new therapy may be effective for many patients,” Professor Morand said.
”As the drug has been on the market for some time for other diseases, it can be rapidly put into formal trials for lupus treatment right away.”
Learn more: Promising new treatment for lupus on the horizon
The Latest on: Lupus
via Google News
The Latest on: Lupus
- Family wants to raise awareness after losing mother to rare fungus on April 17, 2019 at 7:36 pm
Stephanie Spoor, 64, was being treated for complications from lupus and was in need of a lung transplant. Her family says she contracted Candida auris, a fungus that’s resistant to multiple anti ... […]
- Family of Chicago-area woman who died hopes officials will lift secrecy on Candida auris fungus on April 17, 2019 at 6:00 pm
Stephanie Spoor lived with lupus for three decades. But after suffering heart failure and becoming infected with a recent outbreak of a deadly fungus, she survived less than two months. Spoor’s family ... […]
- Alva woman delivers supplies, joy despite diagnosis of incurable disease on April 17, 2019 at 3:00 pm
One Alva woman delivers hope to Southwest Florida patients in need. When Jennifer Scalora, 51, was diagnosed with Lupus, the same incurable disease she lost her mother to, Scalora wasn’t about to give ... […]
- Lupus Foundation of America Provides Voice for Childhood Lupus Community at CARRA Meeting on April 17, 2019 at 1:07 pm
Last week several Lupus Foundation of America research team members, advocates and Board leadership joined clinicians, researchers, fellows and key opinion leaders for the 2019 CARRA Annual Meeting. ... […]
- Lena Harris Foundation Hopes To “Make The World Around Us A Better Place” on April 17, 2019 at 7:42 am
Edison, NJ - Just a few months ago, Joseph Johnson, a recent Monmouth University graduate, created the Lena Harris Foundation after his grandmother died from Lupus. The Foundation is already making a ... […]
- Ocean City To Host Walk To End Lupus on April 17, 2019 at 7:19 am
The Walk To End Lupus Now South Jersey takes place Sunday, May 19 at the Ocean City Boardwalk. (Image via YouTube) OCEAN CITY, N.J. — Ocean City will host the 11th Annual Walk To End Lupus Now ... […]
- New Research Sheds Light on Cellular Fluctuations in Pregnant Women with Lupus on April 17, 2019 at 5:10 am
Systemic lupus erythematosus (SLE) carries an increased risk of pregnancy complications, including preeclampsia and fetal adverse outcomes. Researchers studied women with lupus comparing their blood ... […]
- Lupus Therapeutic 2019 Global Market Outlook,Research,Trends and Forecast to 2023 on April 17, 2019 at 5:07 am
The analysts forecast the global lupus therapeutic market to grow at a CAGR of 9.74% during the period 2017-2021. Lupus is a chronic autoimmune disease in which the body’s immune system becomes ... […]
- What Role Do Commensal Bacteria Play in Triggering Autoimmunity in Lupus? on April 16, 2019 at 12:42 pm
Physician Editor of Dermatology World, Kathryn Schwarzenberger, MD talks with Teri Greiling, MD, PhD, about her recent Science Translational Medicine article,"Commensal orthologs of the human ... […]
- College student, 19, meets liver donor, 22, who stepped in to save her from life-threatening lupus on April 16, 2019 at 4:21 am
This is the heart-touching moment that a college student met the stranger who saved her life by donating part of his liver to her. Madison Ricci, 19, from Hamden, Connecticut, was diagnosed with lupus ... […]
via Bing News